Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced the pricing of an underwritten public offering of 3,030,303 shares of its common stock at a price to the public of $33.00 per share.
June 3, 2020
· 4 min read